top of page

SGLT2-Inhibitor Induced Euglycemic Diabetic Ketoacidosis (EuDKA) - #MEDSHED

Updated: Jan 15

Welcome to the #MEDSHED! Needing a brief, concise review of clinical pharmacotherapy and disease management? Direct links of reference to content discussed? Look no further than the #MEDSHED series based on infographics and carousel presentations!
 


 

🥞 SLGT-2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis (EuDKA) - #MEDSHED



🍐 Sodium-glucose transporter type 2 (SGLT-2) inhibitors are FDA-approved for type 2 diabetes mellitus (T2DM)



🍎 Mechanism: Inhibition of SGLT-2 results in reduced glucose reabsorption in the proximal renal tubules



🌊 SGLT-2 inhibitors have seen increased prescribing from trials having positive outcomes in renal, cardiovascular, and all-cause mortality



🍚 Diabetic ketoacidosis manifests from counterregulatory hormones during acute stress responses in the setting of insulin deficiency



🍖 SGLT-2 inhibiters promote glucosuria (excessive glucose in urine) leading to “normal” serum glucose



🏃 Counterregulatory hormones break down free fatty acids combined with SGLT-2 inhibitor glucosuria results in euglycemic diabetic ketoacidosis (EuDKA)



🎥 Fluid Resuscitation


Crystalloid fluids 1 - 1.5 L within 1st hour


Subsequent fluid selection based on hydration, serum electrolytes, & urinary output


🤖 Insulin Therapy


0.1 unit/kg/hr IV infusion, questionable benefit of IV bolus


Transition with AMS resolution, anion gap closure, PO intake, optimized subq insulin regimen


📋 Electrolytes


Hypokalemia and hypoglycemia are most common (consider potassium-containing fluids)


If BG < 250 mg/dL & anion gap remain elevated, start dextrose-containing fluids for insulin to continue running



🎥 For more #PHARMFAX in the drug bank, share the #MEDSHED with a friend, check out another post on my page, and I hope you learned something new.







Social Media: linktr.ee/pharmwyze




Not medical advice. Educational purposes only. No relationships to report.



27 views0 comments

コメント


bottom of page